Skip to main content

Table 4 Ongoing clinical trials using adoptive cell therapy in breast cancer patients

From: Mechanisms of immune evasion in breast cancer

Patient population

Intervention

Phase

Country

NIH No

Metastatic breast cancer refractory to at least 1 standard therapy

cMet CAR RNA T Cells Targeting Breast Cancer

I

USA

NCT01837602

Malignant pleural disease, Mesothelioma, Lung Cancer, Breast Cancer

Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin

I

USA

NCT02414269

Solid tumors

Tumor Associated Antigen (TAA)-Specific Cytotoxic T-Lymphocytes

I

USA

NCT02239861

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us